MR编号 | UK/H/6866/001 | ||||||
---|---|---|---|---|---|---|---|
药品名称 | Clobazam 5/5 mg/ml Oral suspension | ||||||
活性成分 |
| ||||||
剂型 | Oral suspension | ||||||
上市许可持有人 | Teva Pharmaceuticals Europe B.V. [C/O Teva UK Ltd,] Field House Station Approach Harlow Essex CM20 2FB United Kingdom | ||||||
参考成员国 - 产品名称 | United Kingdom (GB) | ||||||
互认成员国 - 产品名称 |
| ||||||
许可日期 | 2018/12/17 | ||||||
最近更新日期 | 2019/08/28 | ||||||
药物ATC编码 |
申请类型 | 附件文件下载 | 市场状态 | Withdrawn(注:已撤市) | 撤市原因:2.The company decided to withdraw the application. At the time of withdrawal, the MS considered that the data provided could allow to conclude on a positive benefit-risk balance if the points for clarification identified were solved. |